San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia – the Santa Clara tech ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Biotechnology company Regeneron pledged to put in $120 million and genetic sequencing company Illumina is investing $20 million. The rest will come from U.S. health systems including New York ...

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing ...

Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...

ILMN teams up with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data.

Illumina & NVIDIA collaborate to decode biology and propel precision health: San Diego Wednesday, January 15, 2025, 16:00 Hrs [IST] Illumina, Inc., a global leader in genomic sequ ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on ILMN stock, giving a Buy rating on January 10.Stay Ahead of the ...